The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 215-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 215-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice

By Wang Gang   Badylak Stephen F   Heber-Katz Ellen   Braunhut Susan J   Gudas Lorraine J  

Regenerative Medicine, Vol. 5, Iss. 2, 2010-03 ,pp. : 201-220

Future Medicine

Access to resources Recommend Favorite

Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms

By      

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 513-532

Spandidos Publications

Access to resources Recommend Favorite

3D QSAR and docking studies of a series of histone deacetylase inhibitors

By Li Xiaoguang   Zhang Yingjie   Zhang Lei   Xu Yingying   Xu Wenfang  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2229-2241

Springer Publishing Company

Access to resources Recommend Favorite